Immunity, inflammation, and cancer: an eternal fight between good and evil.
about
Multi-organ Mapping of Cancer RiskTargeting microRNAs as key modulators of tumor immune responseThe Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with InflammationTumor-Derived Exosomes and Their Role in Tumor-Induced Immune SuppressionThe inflammasome: an emerging therapeutic oncotarget for cancer preventionNOS2 expression in glioma cell lines and glioma primary cell cultures: correlation with neurosphere generation and SOX-2 expression.GFI1 downregulation promotes inflammation-linked metastasis of colorectal cancer.Targeting Tumor Microenvironment: Effects of Chinese Herbal Formulae on Macrophage-Mediated Lung Cancer in Mice.The cancer theory of pulmonary arterial hypertension.Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation.MLL1 is essential for the senescence-associated secretory phenotypeIL-17A-producing T cells are associated with the progression of lung adenocarcinomaHigh Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma.Tracking Cancer Genetic Evolution using OncoTrack.Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation.High fat diet increases melanoma cell growth in the bone marrow by inducing osteopontin and interleukin 6Leveraging premalignant biology for immune-based cancer prevention.The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.Prognostic Value of the Combination of Preoperative Hemoglobin, Lymphocyte, Albumin, and Neutrophil in Patients with Locally Advanced Colorectal CancerRig-G is a growth inhibitory factor of lung cancer cells that suppresses STAT3 and NF-κB.Helicobacter pylori-induced cell death is counteracted by NF-κB-mediated transcription of DARPP-32Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma.Selected patients can benefit more from the management of etoposide and platinum-based chemotherapy and thoracic irradiation-a retrospective analysis of 707 small cell lung cancer patients.Heterogeneity in Cancer Metabolism: New Concepts in an Old Field.Cancer immunotherapy: harnessing the immune system to battle cancer.Immune suppressive mechanisms in the tumor microenvironment.Differences of immune disorders between Alzheimer's disease and breast cancer based on transcriptional regulation.Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.Melanocytic nevi and melanoma: unraveling a complex relationship.The role of connexin and pannexin containing channels in the innate and acquired immune response.Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.Connexins and their channels in inflammation.Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment.HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarminsHeralding a new paradigm in 3D tumor modeling.Prognostic Role of the Pretreatment C-Reactive Protein/Albumin Ratio in Solid Cancers: A Meta-Analysis.Endoplasmic reticulum proteostasis: a key checkpoint in cancer.Systemic treatment for hepatocellular carcinoma: Still unmet expectationsRecent Advances in Nanoparticle-Mediated Delivery of Anti-Inflammatory PhytocompoundsImmunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy.
P2860
Q26701396-9ACAA4A8-F752-4CA1-BBEB-A3BE7982CDF8Q26746972-F430E42F-E731-4CE3-8F3D-CF558A91FA04Q28073691-7F9844C3-E422-44BF-91A2-9D15A56945F7Q28076769-DA0B8809-DFBB-431B-94AC-46FD15999016Q28076914-02EF5348-8122-4C76-9F8A-B2467BBF1EF8Q33648954-0263DE0B-5F00-4C47-BDA8-F869F57D033FQ33652169-98BDB011-BC79-432D-9917-AE667769AE0FQ33786852-5A7D901F-38EE-4EA6-9C34-DB606CE45995Q33788493-D6CFC76C-4C8D-45C3-922F-811C48426745Q33848444-CF79AD42-6443-40B4-AB34-385CED3F108AQ36549519-9FC8E2F1-F55D-41CD-A56B-4ECC4639F8E2Q37066685-A6F7174F-937E-49A1-9472-1C9018B7E99AQ37067601-5F95FF8B-7CD3-4415-B0F0-97F94C667A9BQ37093114-F2468B19-0743-4980-8460-317C3533551EQ37262555-7504CE43-4456-41E3-82E6-A26932384D7FQ37295749-D0DA4C0A-323C-4325-98C2-2CE3944CC983Q37304964-F55CA83F-12A4-4CF0-A858-656F54A54F9FQ37366321-F12B200C-547D-4120-BFF1-BF29E2AD30F4Q37540276-9FC940F7-9E62-4DBB-89DD-990F16F0688EQ37662354-9A6520BB-289E-44D1-8A69-DDB6A2E4139CQ37678094-68C6C56D-BA50-4D22-A78F-D74AF1A81E82Q37685665-DF6C8C4A-4945-460C-B2B0-745D3451A871Q37702774-943D4A1C-D7C5-46C8-9911-ED15B886B4DCQ37713095-8CCD5BE7-2C06-4949-B06E-8B07B7B5A066Q38577828-E9E66EB5-1E41-465B-B92F-F54B037F24E0Q38648567-FA88E126-79F0-45C5-B3E3-303E0016CA3DQ38673763-29ED817B-40C1-465F-83A4-D32E673B5DCFQ38729973-4A6940E3-8626-4420-89D7-979080349298Q38730348-7D9F4A05-F1B7-4DC8-AF2C-0DA9B27AD2D3Q38755727-1AA55EAB-5E75-4159-AE34-D4370F616789Q38823649-96A2B819-DEFB-4ADD-9725-5288D58B3FD6Q38888995-19CF5856-66DA-4FA1-A6CD-78090E2D7DD7Q38897741-1104C71F-FABD-4EFC-AFE4-DCED870A6A11Q38939435-50190858-4BBE-45E8-812C-7F9FE4F24362Q38957511-8AE31FB7-D2BE-4ED1-B10C-D4BCCEBB9272Q38995892-F84EFA04-A74C-4148-B1BE-5A966B0B6C67Q39011260-59DFC773-1861-4082-8B77-5756FD22FCC7Q39112745-6019185E-3929-429B-9FC2-7F578ED942ABQ39204729-92772FCC-D6E3-452E-9165-D54EB2C7BA9BQ40045752-B60FB859-B97A-420C-B697-36D69B507FC4
P2860
Immunity, inflammation, and cancer: an eternal fight between good and evil.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immunity, inflammation, and cancer: an eternal fight between good and evil.
@ast
Immunity, inflammation, and cancer: an eternal fight between good and evil.
@en
type
label
Immunity, inflammation, and cancer: an eternal fight between good and evil.
@ast
Immunity, inflammation, and cancer: an eternal fight between good and evil.
@en
prefLabel
Immunity, inflammation, and cancer: an eternal fight between good and evil.
@ast
Immunity, inflammation, and cancer: an eternal fight between good and evil.
@en
P2860
P356
P1476
Immunity, inflammation, and cancer: an eternal fight between good and evil.
@en
P2093
Shabnam Shalapour
P2860
P304
P356
10.1172/JCI80007
P407
P577
2015-09-01T00:00:00Z